152 related articles for article (PubMed ID: 8634616)
1. Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study.
Langham S; Thorogood M; Normand C; Muir J; Jones L; Fowler G
BMJ; 1996 May; 312(7041):1265-8. PubMed ID: 8634616
[TBL] [Abstract][Full Text] [Related]
2. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
[TBL] [Abstract][Full Text] [Related]
3. What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.
Wonderling D; Langham S; Buxton M; Normand C; McDermott C
BMJ; 1996 May; 312(7041):1274-8. PubMed ID: 8634618
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. Imperial Cancer Research Fund OXCHECK Study Group.
BMJ; 1994 Jan; 308(6924):308-12. PubMed ID: 8124120
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. Imperial Cancer Research Fund OXCHECK Study Group.
BMJ; 1991 May; 302(6784):1057-60. PubMed ID: 2036503
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group.
BMJ; 1995 Apr; 310(6987):1099-104. PubMed ID: 7742676
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of the population-based Check your health preventive programme conducted in primary care with 4 years follow-up [the CORE trial]: study protocol for a randomised controlled trial.
Maindal HT; Støvring H; Sandbaek A
Trials; 2014 Aug; 15():341. PubMed ID: 25169211
[TBL] [Abstract][Full Text] [Related]
8. Intensive cardiovascular risk factor intervention in a rural practice: a glimmer of hope?
Roberts A; Roberts P
Br J Gen Pract; 1998 Feb; 48(427):967-70. PubMed ID: 9624766
[TBL] [Abstract][Full Text] [Related]
9. Strategies for reducing coronary risk factors in primary care: which is most cost effective?
Field K; Thorogood M; Silagy C; Normand C; O'Neill C; Muir J
BMJ; 1995 Apr; 310(6987):1109-12. PubMed ID: 7742678
[TBL] [Abstract][Full Text] [Related]
10. The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check.
O'Neill C
Health Rep; 1994; 6(1):160-5. PubMed ID: 7919075
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of a cardiovascular risk reduction program in general practice.
Salkeld G; Phongsavan P; Oldenburg B; Johannesson M; Convery P; Graham-Clarke P; Walker S; Shaw J
Health Policy; 1997 Aug; 41(2):105-19. PubMed ID: 10169297
[TBL] [Abstract][Full Text] [Related]
12. Randomised controlled trial comparing uptake of NHS Health Check in response to standard letters, risk-personalised letters and telephone invitations.
Gidlow CJ; Ellis NJ; Riley V; Chadborn T; Bunten A; Iqbal Z; Ahmed A; Fisher A; Sugden D; Clark-Carter D
BMC Public Health; 2019 Feb; 19(1):224. PubMed ID: 30791884
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
Mihaylova B; Briggs A; Armitage J; Parish S; Gray A; Collins R;
Lancet; 2005 May 21-27; 365(9473):1779-85. PubMed ID: 15910950
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
[TBL] [Abstract][Full Text] [Related]
15. Prevention in practice: results of a 2-year follow-up of routine health promotion interventions in general practice.
Dowell AC; Ochera JJ; Hilton SR; Bland JM; Harris T; Jones DR; Katbamna S
Fam Pract; 1996 Aug; 13(4):357-62. PubMed ID: 8872092
[TBL] [Abstract][Full Text] [Related]
16. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs.
Rasmussen SR; Thomsen JL; Kilsmark J; Hvenegaard A; Engberg M; Lauritzen T; Søgaard J
Scand J Public Health; 2007; 35(4):365-72. PubMed ID: 17786799
[TBL] [Abstract][Full Text] [Related]
17. Healthcare and patient costs of a proactive chlamydia screening programme: the Chlamydia Screening Studies project.
Robinson S; Roberts T; Barton P; Bryan S; Macleod J; McCarthy A; Egger M; Sanford E; Low N;
Sex Transm Infect; 2007 Jul; 83(4):276-81. PubMed ID: 17229792
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
[TBL] [Abstract][Full Text] [Related]
20. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
Trials; 2015 Dec; 16():554. PubMed ID: 26637993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
